DXCM Congressional Stock Trades
DEXCOM, INC. CMN
Last disclosed trade Jun 30
Every disclosed trade in DXCM by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Coldpine’s read
Smith's seats on the Finance and Banking Committees give her exposure to healthcare and device-sector policy relevant to DexCom. The three-day disclosure lag is unusually fast, making this spouse-attributed sale recent and actionable. Two other members sold the same name within 30 days, indicating possible cluster behavior worth monitoring.
Tina Smith · Sold · May 7
Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →
Follow $DXCM
Get notified when any member of Congress trades $DXCM. Free, no card, no spam.
Members who trade DXCM
Recent disclosed trades in DXCM
| Date | Member | Type | Amount |
|---|---|---|---|
| Jun 30 | Rohit Khanna(CA) | sell | $1K–$15K |
| May 7 | Tina Smith(MN) | sell | $100K–$250K |
| May 7 | Michael T. McCaul(TX) | sell | $1K–$15K |
| Apr 29 | Tina Smith(MN) | sell | $100K–$250K |
| Apr 24 | Rohit Khanna(CA) | sell | $1K–$15K |
| Apr 13 | Rohit Khanna(CA) | buy | $1K–$15K |
| Feb 4 | Michael T. McCaul(TX) | sell | $1K–$15K |
| Jan 26 | John Boozman(AR) | buy | $1K–$15K |
| Dec 12 | Rohit Khanna(CA) | buy | $1K–$15K |
| Dec 5 | Rohit Khanna(CA) | buy | $1K–$15K |
| Oct 27 | Michael T. McCaul(TX) | sell | $15K–$50K |
| Sep 29 | Rohit Khanna(CA) | sell | $1K–$15K |
| Aug 21 | Michael T. McCaul(TX) | sell | $1K–$15K |
| Aug 7 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Aug 4 | Michael T. McCaul(TX) | buy | $1K–$15K |
| May 28 | Rohit Khanna(CA) | buy | $1K–$15K |
| May 15 | Rob Bresnahan(PA) | buy | $1K–$15K |
| Apr 8 | Michael T. McCaul(TX) | buy | $50K–$100K |
| Apr 8 | Rob Bresnahan(PA) | sell | $1K–$15K |
| Mar 13 | Michael T. McCaul(TX) | sell | $15K–$50K |
Showing 20 of 35 disclosed trades.
Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.
Create a free accountData sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →